{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:13:43Z","timestamp":1791486823696,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004951","name":"Ataturk University","doi-asserted-by":"publisher","award":["TDK-2022-11256"],"award-info":[{"award-number":["TDK-2022-11256"]}],"id":[{"id":"10.13039\/501100004951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["119C134"],"award-info":[{"award-number":["119C134"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.chroma.2025.465741","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:11:03Z","timestamp":1738174263000},"page":"465741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Method development and validation for determination of N-Nitrosamines in pharmaceutical preparations by LC-MS\/MS: Application to extractables and leachables studies"],"prefix":"10.1016","volume":"1745","author":[{"given":"O\u011fuzhan","family":"Dalk\u0131l\u0131\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim Hakk\u0131","family":"Demircio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saffet","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-2959","authenticated-orcid":false,"given":"Hasan","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-950X","authenticated-orcid":false,"given":"Tugrul Cagri","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-809X","authenticated-orcid":false,"given":"Alptu\u011f","family":"Atila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdullah","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Kandemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.465741_bib0001","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/acs.jmedchem.0c02120","article-title":"Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities","volume":"64","author":"Bharate","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0002","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.xphs.2021.02.028","article-title":"Tolerability of risk: a commentary on the nitrosamine contamination issue","volume":"110","author":"Elder","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2025.465741_bib0003","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1021\/acs.joc.0c02774","article-title":"An Organic Chemist's Guide to N-Nitrosamines: Their Structure, Reactivity, and Role as Contaminants","volume":"86","author":"Beard","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2021.100186","article-title":"Developing structure-activity relationships for N-nitrosamine activity","volume":"20","author":"Cross","year":"2021","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.chroma.2025.465741_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3945\/ajcn.112.043885","article-title":"Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study","volume":"97","author":"Keszei","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.chroma.2025.465741_bib0006","unstructured":"European Medicines Agency, EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity: some valsartan medicines being recalled across the EU, (2018). https:\/\/www.ema.europa.eu\/en\/news\/ema-reviewing-medicines-containing-valsartan-zhejiang-huahai-following-detection-impurity-some-valsartan-medicines-being-recalled-across-eu."},{"key":"10.1016\/j.chroma.2025.465741_bib0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpba.2019.05.022","article-title":"The contamination of valsartan and other sartans, part 1: New findings","volume":"172","author":"S\u00f6rgel","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465741_bib0008","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.3390\/molecules25225304","article-title":"N-Nitrosodimethylamine Contamination in the Metformin Finished Products","volume":"25","author":"Zmys\u0142owski","year":"2020","journal-title":"Mol"},{"key":"10.1016\/j.chroma.2025.465741_bib0009","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.oprd.3c00100","article-title":"The Nitrosamine \u201cSaga\u201d: Lessons Learned from Five Years of Scrutiny","volume":"27","author":"Nudelman","year":"2023","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.chroma.2025.465741_bib0010","unstructured":"U.S. Food and Drug Administration, Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) Guidance for Industry Control of Nitrosamine Impurities in Human Drugs Guidance for Industry, (2023). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cder-nitrosamine-impurity-acceptable-intake-limits."},{"key":"10.1016\/j.chroma.2025.465741_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126752","article-title":"A comprehensive approach for N-nitrosamine determination in pharmaceuticals using a novel HILIC-based solid phase extraction and LC-HRMS","volume":"282","author":"Planin\u0161ek Parfant","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.chroma.2025.465741_bib0012","unstructured":"European Medicines Agency, Questions and answers for marketing authorisation holders\/applicants on the CHMP opinion for the Article 5 (3) of Regulation (EC) No 726\/2004 referral on nitrosamine impurities in human medicinal products., (2020) 1\u201351. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders-applicants-chmp-opinion-article-53-regulation-ec-no-726-2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf."},{"key":"10.1016\/j.chroma.2025.465741_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116286","article-title":"Analytical challenges and recent advances in the identification and quantitation of extractables and leachables in pharmaceutical and medical products","volume":"141","author":"Singh","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4236\/ajac.2013.46035","article-title":"Analysis of N-Nitrosamine Migration from Rubber Teats and Soothers","volume":"2013","author":"Mutsuga","year":"2013","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0015","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1021\/es049846j","article-title":"Detecting N-Nitrosamines in Drinking Water at Nanogram per Liter Levels Using Ammonia Positive Chemical Ionization","volume":"38","author":"Charrois","year":"2004","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chroma.2025.465741_bib0016","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1021\/acsomega.1c00982","article-title":"Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients","volume":"6","author":"Wichitnithad","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.chroma.2025.465741_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113460","article-title":"Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography\u2013tandem mass spectrometry","volume":"189","author":"Lim","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.chroma.2025.465741_bib0018","first-page":"1","article-title":"Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products","volume":"91","author":"Masada","year":"2019","journal-title":"Sci. Reports"},{"key":"10.1016\/j.chroma.2025.465741_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9673(01)01547-3","article-title":"Fast microwave-assisted dansylation of N-nitrosamines: Analysis by high-performance liquid chromatography with fluorescence detection","volume":"946","author":"C\u00e1rdenes","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465741_bib0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/ac701804y","article-title":"Analysis of nitrosamines in wastewater: Exploring the trace level quantification capabilities of a hybrid linear ion trap\/orbitrap mass spectrometer","volume":"80","author":"Krauss","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0021","first-page":"1730","article-title":"Simultaneous Determination of Alkaloids and Their Related Tobacco-Specific Nitrosamines in Tobacco Leaves Using LC\u2013MS-MS","volume":"53","author":"Li","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.chroma.2025.465741_bib0022","doi-asserted-by":"crossref","first-page":"292","DOI":"10.38212\/2224-6614.1063","article-title":"A multi-analyte LC-MS\/MS method for screening and quantification of nitrosamines in sartans","volume":"28","author":"Chang","year":"2020","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.chroma.2025.465741_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114867","article-title":"Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry","volume":"218","author":"Luo","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465741_bib0024","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhazmat.2016.02.048","article-title":"Elevated urinary levels of carcinogenic N-nitrosamines in patients with urinary tract infections measured by isotope dilution online SPE LC\u2013MS\/MS","volume":"310","author":"Hu","year":"2016","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.chroma.2025.465741_bib0025","series-title":"ICH Harmonised Guideline, Validation of Analytical Procedures Q2(R1)","year":"2005"},{"key":"10.1016\/j.chroma.2025.465741_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.124102","article-title":"Current status and prospects of development of analytical methods for determining nitrosamine and N-nitroso impurities in pharmaceuticals","volume":"254","author":"Wichitnithad","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.chroma.2025.465741_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123593","article-title":"Development of a sensitive LC-APCI-MS\/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach","volume":"1216","author":"Mavis","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2025.465741_bib0028","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2019.04.049","article-title":"Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography","volume":"174","author":"Schmidtsdorff","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465741_bib0029","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jchromb.2009.03.009","article-title":"Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine","volume":"877","author":"Kavvadias","year":"2009","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2025.465741_bib0030","first-page":"74","article-title":"New LC-MS\/MS method for the determination of eight nitrosamines in drinking water","volume":"17","author":"Galaon","year":"2016","journal-title":"J. Environ. Prot. Ecol."},{"key":"10.1016\/j.chroma.2025.465741_bib0031","first-page":"1","article-title":"Test method for the determination of NDMA by LC\/MS\/MS in Valsartan finished products","volume":"7","author":"El-Atma","year":"2018","journal-title":"Chem. Und Veterin\u00e4runtersuchungsamt"},{"key":"10.1016\/j.chroma.2025.465741_bib0032","first-page":"1","article-title":"Combined N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Impurity Assay by GC\/MS-Headspace","year":"2019","journal-title":"US Food Drug Adm."},{"key":"10.1016\/j.chroma.2025.465741_bib0033","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1063\/1.555680","article-title":"The Solubility of Oxygen and Ozone in Liquids","volume":"12","author":"Battino","year":"1983","journal-title":"J. Phys. Chem. Ref. Data"},{"key":"10.1016\/j.chroma.2025.465741_bib0034","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1021\/acs.joc.0c02774","article-title":"An Organic Chemist's Guide to N-Nitrosamines: Their Structure, Reactivity, and Role as Contaminants","volume":"86","author":"Beard","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chroma.2025.465741_bib0035","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1021\/es051235j","article-title":"UV photolytic mechanism of N-nitrosodimethylamine in water: Roles of dissolved oxygen and solution pH","volume":"39","author":"Lee","year":"2005","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chroma.2025.465741_bib0036","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/jps.22012","article-title":"On Developing a Process for Conducting Extractable\u2013Leachable Assessment of Components Used for Storage of Biopharmaceuticals","volume":"99","author":"Wakankar","year":"2010","journal-title":"J. Pharm. Sci."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:08:51Z","timestamp":1777410531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"alternative-id":["S0021967325000901"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465741","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Method development and validation for determination of N-Nitrosamines in pharmaceutical preparations by LC-MS\/MS: Application to extractables and leachables studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"465741"}}